Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals

ABSTRACT In the absence of effective vaccines and with limited therapeutic options, convalescent plasma is being collected across the globe for potential transfusion to coronavirus disease 2019 (COVID-19) patients. The therapy has been deemed safe, and several clinical trials assessing its efficacy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Guillaume Beaudoin-Bussières, Annemarie Laumaea, Sai Priya Anand, Jérémie Prévost, Romain Gasser, Guillaume Goyette, Halima Medjahed, Josée Perreault, Tony Tremblay, Antoine Lewin, Laurie Gokool, Chantal Morrisseau, Philippe Bégin, Cécile Tremblay, Valérie Martel-Laferrière, Daniel E. Kaufmann, Jonathan Richard, Renée Bazin, Andrés Finzi
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
coronavirus
COVID-19
SARS-CoV-2
Spike glycoproteins
RBD
ELISA
Microbiology
QR1-502
Acceso en línea:https://doaj.org/article/ffd03ff044094e43ad2ac82e96e702dd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/ffd03ff044094e43ad2ac82e96e702dd

Ejemplares similares